Saturday, August 8, 2020

Relief Therapeutics sees 60-70% chance of COVID-19 drug approval

Relief Therapeutics sees 60-70% chance of COVID-19 drug approval The Swiss group owns the rights to the drug in the United States and Europe.

from Moneycontrol Business News https://ift.tt/2PzCUk3

No comments:

Post a Comment

Sensex, Nifty slip 0.7% as Fed’s cautious outlook damps investor sentiment

Indian stock markets experienced a decline on Thursday. The NSE Nifty and BSE Sensex closed lower. This downturn followed the US Federal Res...